Randomized, Double-Blind, Vehicle Controlled, Phase 2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Activity of Topical ATx201 GEL (2% and 4%) in Outpatients With Impetigo
Phase of Trial: Phase II
Latest Information Update: 07 Aug 2018
At a glance
- Drugs Niclosamide (Primary)
- Indications Impetigo
- Focus Adverse reactions
- Sponsors AntibioTx
- 30 Jul 2018 Status changed from recruiting to completed.
- 01 Mar 2018 Status changed from not yet recruiting to recruiting.
- 14 Feb 2018 New trial record